Case Study multi-national pharma company

Case study: global serialization project

SEA Vision supports multi-national pharma company with serialization processes across 200 production lines SEA Vision and Zenith Technologies support pharmaceutical companies with the design, installation and integration of serialization technology and processes across manufacturing sites. Multi-site implementation can often be a challenge for companies without dedicated resources in place. In this case study, a combined…

Technology selection barrier serialization

Technology selection identified as biggest hurdle in serialization race for compliance

Technology selection, a barrier to serialization New industry research explores the greatest barriers to serialization success as companies across the pharmaceutical supply chain prepare for new regulations in the US and Europe. The research, conducted by serialization system provider SEA Vision and life science technology specialist Zenith Technologies, highlights technology selection as the biggest challenge…

serialization strategic planning

Ahead of the curve: planning for serialization

Implementing a serialization solution in time for new regulations in the US and Europe is a huge task. Serialization will transform the entire supply chain and requires pharmaceutical manufacturers to invest in new technology, adapt their current processes and systems and ensure staff understands the new regulatory environment in which they are working. With so…

Beyond compliance: serialization across the globe

By 2020 most major markets will have pharmaceutical serialization regulations in place, however it is not a one size fits all scenario with requirements and timelines differing across countries. In the third part of our Serialization Series, Zenith Technologies’ serialization director, Carlos Machado and our senior R&D product manager Matteo Barbieri discuss the different approaches…

Pharmaceutical Serialization for Late Starters – With Live Industry Research Results

In this live session, entitled ‘pharmaceutical serialization for late starters’, Carlos Machado, serialization director at Zenith Technologies / SEA Vision US and Paolo Landriani, product manager at SEA Vision Italy will offer insight on how companies within the pharmaceutical industry can prepare for upcoming serialization regulations, with a view to guaranteeing long term success and…

pharmaceutical serialization drivers

Safety first: drivers of serialization

PHARMACEUTICAL SERIALIZATION KEY DRIVERS – PART 2 Pharmaceutical serialization drivers have been well discussed, with sales of counterfeit drugs now amounting to $75 billion annually and the overall value of the falsified drugs market estimated at around $200 billion. In this second part (read the first article here) of our Serialization Series, Zenith Technologies’ serialization director,…

drug serialization

Opportunity knocks: drug serialization in Europe and the US

Welcome to our Serialization Series. Wondering how to comply with the newest drug serialization regulations on time, on budget and with perfect execution? You’re in the right place. In this blog, Matteo Barbieri, senior R&D product manager at SEA Vision and Zenith Technologies’ serialization director, Carlos Machado talk us through some of the key challenges…

implementing pharmaceutical serialization

Implementing pharmaceutical serialization

Implementing pharmaceutical serialization across a diverse manufacturing environment – part 1 As the US and European deadlines for pharmaceutical serialization get closer, the challenge of implementing pharmaceutical serialization solution on time is greater than ever. In order to ensure full compliance when the new regulations come into force, manufacturers should already be considering the best approach…